HarmonyCA – Allergan

HarmonyCA – Allergan

Allergan the French leader in injectables, precursor in anti-aging products to launch HARmonyCA, a combined injectable of Hyaluronic acid and Collagen.

A revolution in injectable aesthetic medicine products

Features

Global pharmaceutical company Allergan Aesthetics has launched HARmonyCa, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).

HARmonyCa has a dual effect, with HA providing an immediate lift and CaHA causing new collagen production.

HarmonyCa is intended for the augmentation of loose facial tissue by injection into the deep dermal and subdermal layers.

Results

The cross-linked HA gel provides an immediate lifting effect and is moldable, allowing a qualified aesthetic practitioner to adjust the shape of the implant after administration

Hyaluronic acid microspheres, which promote the body’s production of collagen by inducing the formation of collagen fibers

Hyaluronic acid particles work deep in the skin, where they help plump it up for an immediate lifting effect, while CaHA microspheres support the body’s collagen production, so new collagen fibers begin to develop. Newly formed collagen fibers can be present as early as a week after treatment.

Over 90% of patients reported an improvement in the general appearance of facial areas after treatment with HARmonyCa .

It is the first hybrid injectable on the market. Its potential to offer immediate lifting through hyaluronic acid and long-lasting collagen stimulation combined with calcium hydroxyapatite addresses some of the multi-dimensional needs of aging skin.